CUMMINGS KEITH LAMONT (Chief Financial Officer) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/24/2024ACC: 0001746473-24-000014
Officer· Chief Financial Officer
Since Jun 2020
+165.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
165.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+55.25K
Price / share
—
Trade value
—
% of position
28.4%
1/23/2024
194.60K→249.85K
Total
Net shares
+55.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2024 | A · Award | +55.25K | — | — | 28.4% | 194.60K | 249.85K |
| Total | +55.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
110.50K shares
Shares
+110.50K
Strike price
17.44
Held after
110.50K
Exercisable
—
1/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock110.50K shares | 1/23/2024 | A · Award | +110.50K | 17.44 | — | 110.50K |